Oestradiol

Oestradiol (E2) is the most potent and biologically active form of oestrogen in women. It is primarily produced by the ovaries, with smaller amounts made in the adrenal glands, fat tissue, and placenta during pregnancy. Oestradiol is essential for reproductive health, sexual development, bone strength, brain function, and cardiovascular protection. Because it affects nearly every system in the body — from metabolism and mood to collagen and cognition — tracking oestradiol provides powerful insight into overall hormonal balance and wellbeing.

Oestradiol levels normally change across different phases of the menstrual cycle and during perimenopause. The reference ranges below help interpret your oestradiol result based on which phase of your cycle your blood test was taken.

Oestradiol reference ranges in pmol/L:

Follicular phase: 100 - 500

Mid-cycle (ovulatory phase): 250 - 1300

Luteal phase: 200–800

Perimenopausal: <120

Oestradiol regulates the menstrual cycle, supports fertility, and maintains the structure and function of reproductive organs. It strengthens bones by reducing calcium loss, supports healthy cholesterol levels and vascular elasticity, and contributes to sharper cognitive function and stable mood. When oestradiol levels fall too low, women may experience fatigue, hot flashes, vaginal dryness, mood swings, and loss of bone density. When levels are too high, symptoms like breast tenderness, bloating, irritability, and irregular cycles may occur. Understanding where oestradiol sits in relation to a woman’s life stage helps guide individualised care and prevention strategies.

Reproductive Years

During the reproductive years, oestradiol fluctuates in a predictable monthly rhythm. Levels rise in the first half of the menstrual cycle (the follicular phase), peak just before ovulation to stimulate the release of an egg, and fall again before menstruation. Oestradiol also thickens the uterine lining to prepare for potential pregnancy.

• Low oestradiol during this phase may indicate irregular ovulation, hypothalamic or pituitary dysfunction, or excessive stress and undernutrition.

• High oestradiol can occur with polycystic ovary syndrome (PCOS), ovarian cysts, or estrogen dominance. Symptoms may include heavy or irregular periods, mood swings, bloating, and breast tenderness.

• Oestradiol testing can also help monitor fertility treatments, assess menstrual irregularities, or investigate low libido and fatigue.

Pregnancy

During pregnancy, oestradiol levels rise dramatically — up to 100 times higher than baseline — as the placenta becomes the main source of oestrogen production. High oestradiol supports fetal organ development, increases uterine blood flow, and helps prepare the breasts for lactation. It also contributes to the “glow” often experienced in pregnancy due to improved skin elasticity and vascular changes. Abnormally low oestradiol during pregnancy can signal potential complications such as placental insufficiency or threatened miscarriage.

Perimenopause

Perimenopause marks the transition leading up to menopause and is characterised by fluctuating oestradiol levels as ovarian function begins to decline. These hormonal swings often lead to irregular cycles, hot flashes, night sweats, sleep disturbances, mood changes, and increased anxiety. Oestradiol may spike and drop unpredictably during this phase, which can contribute to symptoms like breast tenderness or water retention one month, and low libido or fatigue the next. Monitoring oestradiol alongside FSH and LH during this stage can help determine where a woman is in her transition and guide interventions to stabilise hormones.

Menopause

Menopause is defined as 12 consecutive months without a menstrual period and represents a significant drop in oestradiol production as ovarian follicles are depleted. Oestradiol levels typically fall below 30 pg/mL. The adrenal glands and fat tissue continue to produce small amounts, but this is often insufficient to maintain prior levels of protection. The decline in oestradiol leads to increased bone turnover, raising the risk of osteoporosis and fractures. It also contributes to changes in lipid metabolism, arterial stiffness, and higher cardiovascular risk. Many women experience hot flashes, vaginal dryness, decreased libido, and sleep issues during this time.

Postmenopause

After menopause, oestradiol levels remain low and stable, as ovarian production has essentially ceased. The body relies primarily on peripheral conversion of androgens from fat and adrenal tissue. Low oestradiol at this stage affects multiple systems:

• Bones: Reduced oestrogen accelerates bone loss, increasing fracture risk.

• Heart: The protective effects of oestradiol on arteries diminish, raising cardiovascular risk.

• Skin and Cognition: Collagen decreases, leading to skin thinning, dryness, and memory or concentration changes.

Some women may benefit from bioidentical hormone replacement therapy (HRT) under clinical supervision to manage symptoms and protect long-term health.

Oestradiol levels are influenced by several physiological and lifestyle factors. Chronic stress suppresses reproductive hormones via cortisol’s impact on the HPA axis. Low body weight, overexercise, or restrictive diets can reduce oestrogen production due to limited cholesterol availability. Medications such as oral contraceptives, thyroid drugs, or corticosteroids can also affect E2 levels. Liver health is critical, as oestrogen is metabolised and cleared through hepatic pathways — meaning alcohol overuse or poor detoxification can raise circulating levels.

1. Gruber, C. J., Tschugguel, W., Schneeberger, C., & Huber, J. C. (2002). Production and actions of estrogens. The New England Journal of Medicine, 346(5), 340–352. https://doi.org/10.1056/NEJMra000471

2. Greene, D. N., Ahmed, S. B., Daccarett, S., et al. (2025). A comprehensive review of estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone in the context of laboratory medicine to support women’s health. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvaf039

3. Stevenson, J. C. (2011). A woman’s journey through the reproductive, transitional and postmenopausal periods of life: Impact on cardiovascular and musculo-skeletal risk and the role of estrogen replacement. Maturitas, 70(2), 197–205. https://doi.org/10.1016/j.maturitas.2011.05.017

4. Rieder, J. K., Darabos, K., & Weierich, M. R. (2020). Estradiol and women’s health: Considering the role of estradiol as a marker in behavioral medicine. International Journal of Behavioral Medicine, 27(3), 294–304. https://doi.org/10.1007/s12529-019-09820-4

5. Frederiksen, H., Johannsen, T. H., Andersen, S. E., et al. (2020). Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS. The Journal of Clinical Endocrinology and Metabolism, 105(3), dgz196. https://doi.org/10.1210/clinem/dgz196

6. Biro, F. M., Pinney, S. M., Huang, B., et al. (2014). Hormone changes in peripubertal girls. The Journal of Clinical Endocrinology and Metabolism, 99(10), 3829–3835. https://doi.org/10.1210/jc.2013-4528

7. Clarkson, J. (2013). Effects of estradiol on kisspeptin neurons during puberty. Frontiers in Neuroendocrinology, 34(2), 120–131. https://doi.org/10.1016/j.yfrne.2013.02.002

8. Verdonk, S. J. E., Vesper, H. W., Martens, F., et al. (2019). Estradiol reference intervals in women during the menstrual cycle, postmenopausal women and men using an LC-MS/MS method. Clinica Chimica Acta: International Journal of Clinical Chemistry, 495, 198–204. https://doi.org/10.1016/j.cca.2019.04.062

9. Sherman, B. M., & Korenman, S. G. (1975). Hormonal characteristics of the human menstrual cycle throughout reproductive life. The Journal of Clinical Investigation, 55(4), 699–706. https://doi.org/10.1172/JCI107979

10. Sowers, M. R., Zheng, H., McConnell, D., et al. (2008). Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women. The Journal of Clinical Endocrinology and Metabolism, 93(10), 3847–3852. https://doi.org/10.1210/jc.2008-1056